dc.contributor.author | McEwan, Andrew R | |
dc.contributor.author | MacKenzie, Alasdair | |
dc.date.accessioned | 2020-11-02T10:46:00Z | |
dc.date.available | 2020-11-02T10:46:00Z | |
dc.date.issued | 2020-10-23 | |
dc.identifier | 178920712 | |
dc.identifier | e069b47c-eb27-4ae5-8f0e-4ab69e4505ea | |
dc.identifier | 33113946 | |
dc.identifier | 85094150178 | |
dc.identifier | 000588968500001 | |
dc.identifier.citation | McEwan , A R & MacKenzie , A 2020 , ' Perspective: Quality Versus Quantity; Is It Important to Assess the Role of Enhancers in Complex Disease from an In Vivo Perspective? ' , International Journal of Molecular Sciences , vol. 21 , no. 21 , 7856 . https://doi.org/10.3390/ijms21217856 | en |
dc.identifier.issn | 1422-0067 | |
dc.identifier.uri | https://hdl.handle.net/2164/15304 | |
dc.description | AMcE was funded by BBSRC project grant (BB/N017544/1). | en |
dc.format.extent | 12 | |
dc.format.extent | 404074 | |
dc.language.iso | eng | |
dc.relation.ispartof | International Journal of Molecular Sciences | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject | complex disease | en |
dc.subject | gene regulation | en |
dc.subject | chromatin modification | en |
dc.subject | comparative genomics | en |
dc.subject | CRISPR genome editing | en |
dc.subject | promoter | en |
dc.subject | enhancer | en |
dc.subject | polymorphisms | en |
dc.subject | mental health | en |
dc.subject | alcohol abuse | en |
dc.subject | pharmacogenomics | en |
dc.subject | anxiety | en |
dc.subject | Alcohol abuse | en |
dc.subject | Enhancer | en |
dc.subject | Gene regulation | en |
dc.subject | Mental health | en |
dc.subject | Comparative genomics | en |
dc.subject | Complex disease | en |
dc.subject | Polymorphisms | en |
dc.subject | Promoter | en |
dc.subject | Anxiety | en |
dc.subject | Chromatin modification | en |
dc.subject | Pharmacogenomics | en |
dc.subject | DNA METHYLATION | en |
dc.subject | GENE-REGULATION | en |
dc.subject | TISSUE-SPECIFICITY | en |
dc.subject | REMOTE | en |
dc.subject | SUBSTANCE-P | en |
dc.subject | TRANSCRIPTION | en |
dc.subject | IDENTIFICATION | en |
dc.subject | GENOME | en |
dc.subject | PROMOTER | en |
dc.subject | EXPRESSION | en |
dc.subject | R Medicine | en |
dc.subject | Molecular Biology | en |
dc.subject | Spectroscopy | en |
dc.subject | Catalysis | en |
dc.subject | Inorganic Chemistry | en |
dc.subject | Computer Science Applications | en |
dc.subject | Physical and Theoretical Chemistry | en |
dc.subject | Organic Chemistry | en |
dc.subject | Biotechnology and Biological Sciences Research Council (BBSRC) | en |
dc.subject | BB/N017544/1 | en |
dc.subject.lcc | R | en |
dc.title | Perspective: Quality Versus Quantity; Is It Important to Assess the Role of Enhancers in Complex Disease from an In Vivo Perspective? | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
dc.description.status | Peer reviewed | en |
dc.identifier.doi | https://doi.org/10.3390/ijms21217856 | |
dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85094150178&partnerID=8YFLogxK | en |
dc.identifier.vol | 21 | en |
dc.identifier.iss | 21 | en |